Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Authors
Posts by lungcanc
lungcanc
526 POSTS
0 COMMENTS
Role of Allied Health Professionals in the Multidisciplinary Lung Cancer Team
lungcanc
Exploring the Potential of Immuno-oncology Combination Therapy
lungcanc
Tools for Smoking Cessation
lungcanc
Q & A with Yi-Long Wu, MD
lungcanc
Proton-Beam Therapy Versus Photon-Beam Therapy: The Debate Continues
lungcanc
Deric Savior, MD
lungcanc
Second Annual Lung Cancer Awareness Month to Publicize Research Advances and...
lungcanc
Jean-Charles Soria, MD, PhD
lungcanc
A Surprising Career Advances Cancer Research: Margaret Foti, MD, PhD (hc)
lungcanc
Adjuvant Gefitinib Extended Disease-Free Survival in Patients With Stage II/IIIA Non-Small...
lungcanc
1
...
32
33
34
...
53
Page 33 of 53
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
